gsk and hgs lupus drug wins green light in europe
the first new treatment for lupus in a half-century was recommended for approval in europe on friday, offering a new option for patients and underpinning multibillion-dollar sales expectations for its makers.
http://feeds.reuters.com/~r/reuters/healthnews/~3/7notmdovp9y/us-glaxosmithkline-benlysta-idustre74j3lj20110520
7726
20 May 2011 15:55:51
reuters
health